| Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate New Drug Application Resubmission and PDUFA Date of March 25, 2027 |
Globe Newswire |
10/21 |
07:05 |
| Satellos to Participate in Upcoming Investor Conferences |
Globe Newswire |
10/21 |
07:00 |
| GOWell Energy Technology Reports Operating Subsidiary’s First Half 2026 Financial Results and Provides Corporate Update |
Globe Newswire |
10/21 |
07:00 |
| Tiziana Management Team to Attend the 10th Joint ACTRIMS-ECTRIMS Meeting in Toronto |
Globe Newswire |
10/21 |
07:00 |
| Kaltura to Announce Financial Results for Third Quarter 2026 on Monday, November 9, 2026 |
Globe Newswire |
10/21 |
07:00 |
| Fidelity D & D Bancorp, Inc. Reports Third Quarter 2026 Financial Results |
Globe Newswire |
10/21 |
07:00 |
| Jade Biosciences to Highlight Advancement of JADE101 Development Program at American Society of Nephrology (ASN) Kidney Week 2026 |
Globe Newswire |
10/21 |
07:00 |
| Aeluma Announces Primit Parikh as Strategic Advisor |
Globe Newswire |
10/21 |
07:00 |
| Vivos Therapeutics Reports Nasdaq Confirmation of Compliance with Continued Listing Shareholders’ Equity Standard |
Globe Newswire |
10/21 |
07:00 |
| Arteris to Announce Financial Results for the Third Quarter 2026 on Thursday, November 5, 2026 |
Globe Newswire |
10/21 |
07:00 |
| Winnebago Industries Reports Fourth Quarter and Full Year Fiscal 2026 Results |
Globe Newswire |
10/21 |
07:00 |
| Aya Gold & Silver Files Updated Preliminary Economic Assessment Technical Report for Boumadine Project |
Globe Newswire |
10/21 |
07:00 |
| Auddia Announces Completion of LT350 Phase 1 Feasibility Study and Advancement to Phase 2/3 Engineering with Fresh Consulting |
Globe Newswire |
10/21 |
07:00 |
| What joint replacement involves, from the surgeon's credentials to the recovery plan |
Globe Newswire |
10/21 |
07:00 |
| Roivant to Report Financial Results for the Second Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026 |
Globe Newswire |
10/21 |
07:00 |
| Sotera Health Announces Third-Quarter 2026 Earnings Release Date |
Globe Newswire |
10/21 |
07:00 |
| Opus Genetics Announces FDA Clearance of IND Application for OPGx-RDH12 Gene Therapy for Inherited Childhood Blindness |
Globe Newswire |
10/21 |
07:00 |
| Reborn Coffee Signs Master Product Supply Agreement with Visvita Corporation |
Globe Newswire |
10/21 |
07:00 |
| INmune Bio Establishes Global Commercialization Framework for Ebstrocel™ Through Strategic Agreement with Uniphar |
Globe Newswire |
10/21 |
07:00 |
| Agility Robotics Expands Pittsburgh Presence to Support Growing Customer Deployments |
Globe Newswire |
10/21 |
07:00 |
| PyroGenesis Announces Dubai Subsidiary to Address Growing Opportunities in Middle East and Asian Markets |
Globe Newswire |
10/21 |
07:00 |
| Immunovant to Report Financial Results for the Second Fiscal Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026 |
Globe Newswire |
10/21 |
07:00 |
| OTC Markets Group Names Meighan McGowan Executive Vice President, Corporate Services |
Globe Newswire |
10/21 |
07:00 |
| Stifel Reports Third Quarter 2026 Results |
Globe Newswire |
10/21 |
07:00 |
| Old National Bancorp Reports Record Third Quarter 2026 Results |
Globe Newswire |
10/21 |
07:00 |
